Last reviewed · How we verify

NCT03580577

Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic

Status unknown Last updated 30 July 2018
What this trial tests

trial testing thromboelastography in Liver Cirrhosis in 60 participants. Status unknown.

Timeline
1 September 2018
Primary endpoint
30 June 2019
1 September 2019

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date1 September 2018
Primary completion30 June 2019
Estimated completion1 September 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

16 and older, any sex, with Liver Cirrhosis or Venous Thromboembolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

patient with liver cirrhosis was supposed to have autoanticoagulation which approved to be wrong, with absence of conventional method to detect all abnormalities in coagulation state. Thromboelastography (TEG) give a broad picture for the coagulation defects. In addition to that no guidelines prescribed anticoagulants for venous thromboembolism in cirrhotic, so the investigators will do a study to demonstrate frequency and risk factors for acute venous thromboembolism in cirrhotic patients, find a conventional laboratory method and test TEG to assess risk of thrombosis in cirrhotic patients.Also, to validate current algorithm for use of anticoagulant and antiplatelet for thromboembolism for non cirrhotic in cirrhotic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of thromboelastography

Trials testing the same drug.

Other recruiting trials for Liver Cirrhosis

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03580577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing